What does HEERSE APOTHEEK do?

HEERSE APOTHEEK is a logistics company in Heers. Private Limited, started on 1 July 1999, 1 establishment.

What is the address of HEERSE APOTHEEK?

The registered office of HEERSE APOTHEEK is located at Steenweg(H.) 129, 3870 Heers.

Is HEERSE APOTHEEK still active?

Yes. According to the CBE (29 October 2026) HEERSE APOTHEEK is active, legal situation “Normale toestand”, started on 1 July 1999.

Is HEERSE APOTHEEK registered on Peppol?

Yes, HEERSE APOTHEEK is registered on the Peppol network with ID 0208:0466404110.

What is the enterprise number of HEERSE APOTHEEK?

The enterprise number of HEERSE APOTHEEK is BE0466404110.

When was HEERSE APOTHEEK founded?

HEERSE APOTHEEK was founded on 1 July 1999.

Who are the directors of HEERSE APOTHEEK?

According to the 2025 annual accounts, the directors of HEERSE APOTHEEK are: CHEFAR BV, EUGENE ERNENS.

Is HEERSE APOTHEEK a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 1 July 1999; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did HEERSE APOTHEEK make in 2025?

HEERSE APOTHEEK posted a profit after taxes of € 43,591 in financial year 2025.

What is the revenue of HEERSE APOTHEEK?

As a small company, HEERSE APOTHEEK is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 349,886.

How much does an employee at HEERSE APOTHEEK earn?

The average wage cost per full-time employee at HEERSE APOTHEEK was € 61,600 in 2025: staff costs of € 221,657 for 3.6 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does HEERSE APOTHEEK have?

According to the 2025 annual accounts, HEERSE APOTHEEK has 3.6 full-time equivalents (FTE).

HEERSE APOTHEEK (Private Limited) - Heers - BE0466404110

Dossier HEERSE APOTHEEK, printed on 29 October 2026 from databakkes.be/en/0466404110/heerse-apotheek. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 47 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

HEERSE APOTHEEK from Heers, company number BE0466404110, closed financial year 2025 with a result of € 43,591 after tax. For that financial year HEERSE APOTHEEK recorded a gross margin of € 349,886 and equity of € 151,534. Compared with financial year 2024, the result moved from € 90,269 to € 43,591. The company is profitable. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 16, 2026.

What it is worth Growing

€ 151,534

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 43,591

▼ 52% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 166,351

▼ 31% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 43,500 paid out

100 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents

3.6

▼ 0.3 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 221,657

▲ 20% vs 2024

€ 61,600 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 5,249

▼ 33% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 10 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 667,582

▼ 11% vs 2024

€ 64,746 is repaid this year. At this pace the long-term loan is gone in ≈ 10 years.

Owed to suppliers

€ 151,160

▼ 5% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 83,612

▲ 3% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 502,886 Gross margin 2022: € 502,886 First fiscal year in the series	€ 374,541 Gross margin 2023: € 374,541 ▼ 26% vs 2022 (€ 502,886) Unfavourable step	€ 370,156 Gross margin 2024: € 370,156 ▼ 1% vs 2023 (€ 374,541) Unfavourable step	€ 349,886 Gross margin 2025: € 349,886 ▼ 5% vs 2024 (€ 370,156) Unfavourable step	▼ 5%
Profit after taxes	€ 218,705 Profit after taxes 2022: € 218,705 First fiscal year in the series	€ 108,897 Profit after taxes 2023: € 108,897 ▼ 50% vs 2022 (€ 218,705) Unfavourable step	€ 90,269 Profit after taxes 2024: € 90,269 ▼ 17% vs 2023 (€ 108,897) Unfavourable step	€ 43,591 Profit after taxes 2025: € 43,591 ▼ 52% vs 2024 (€ 90,269) Unfavourable step	▼ 52%
Equity	€ 91,077 Equity 2022: € 91,077 First fiscal year in the series	€ 151,174 Equity 2023: € 151,174 ▲ 66% vs 2022 (€ 91,077) Favourable step	€ 151,443 Equity 2024: € 151,443 Unchanged (€ 151,174) Favourable step	€ 151,534 Equity 2025: € 151,534 Unchanged (€ 151,443) Favourable step
Total debts	€ 1,471,360 Total debts 2022: € 1,471,360 First fiscal year in the series	€ 1,392,639 Total debts 2023: € 1,392,639 ▼ 5% vs 2022 (€ 1,471,360) Favourable step	€ 1,483,240 Total debts 2024: € 1,483,240 ▲ 7% vs 2023 (€ 1,392,639) Unfavourable step	€ 1,421,777 Total debts 2025: € 1,421,777 ▼ 4% vs 2024 (€ 1,483,240) Favourable step	▼ 4%
Cash	€ 205,985 Cash 2022: € 205,985 First fiscal year in the series	€ 149,786 Cash 2023: € 149,786 ▼ 27% vs 2022 (€ 205,985) Unfavourable step	€ 239,512 Cash 2024: € 239,512 ▲ 60% vs 2023 (€ 149,786) Favourable step	€ 166,351 Cash 2025: € 166,351 ▼ 31% vs 2024 (€ 239,512) Unfavourable step	▼ 31%
Land & buildings	€ 967,747 Land & buildings 2022: € 967,747 First fiscal year in the series	€ 924,082 Land & buildings 2023: € 924,082 ▼ 5% vs 2022 (€ 967,747) Unchanged	€ 877,642 Land & buildings 2024: € 877,642 ▼ 5% vs 2023 (€ 924,082) Unchanged	€ 831,203 Land & buildings 2025: € 831,203 ▼ 5% vs 2024 (€ 877,642) Unchanged	▼ 5%
Retained profit	€ 84,077 Retained profit 2022: € 84,077 First fiscal year in the series	€ 144,174 Retained profit 2023: € 144,174 ▲ 71% vs 2022 (€ 84,077) Favourable step	€ 144,443 Retained profit 2024: € 144,443 Unchanged (€ 144,174) Favourable step	€ 144,534 Retained profit 2025: € 144,534 Unchanged (€ 144,443) Favourable step
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 48,800 Dividend 2023: € 48,800 Unchanged (€ 0) Unchanged	€ 90,000 Dividend 2024: € 90,000 ▲ 84% vs 2023 (€ 48,800) Unchanged	€ 43,500 Dividend 2025: € 43,500 ▼ 52% vs 2024 (€ 90,000) Unchanged	▼ 52%
Bank debt	€ 910,482 Bank debt 2022: € 910,482 First fiscal year in the series	€ 829,618 Bank debt 2023: € 829,618 ▼ 9% vs 2022 (€ 910,482) Favourable step	€ 747,566 Bank debt 2024: € 747,566 ▼ 10% vs 2023 (€ 829,618) Favourable step	€ 667,582 Bank debt 2025: € 667,582 ▼ 11% vs 2024 (€ 747,566) Favourable step	▼ 11%
Balance sheet total	€ 1,562,438 Balance sheet total 2022: € 1,562,438 First fiscal year in the series	€ 1,543,813 Balance sheet total 2023: € 1,543,813 ▼ 1% vs 2022 (€ 1,562,438) Unchanged	€ 1,634,683 Balance sheet total 2024: € 1,634,683 ▲ 6% vs 2023 (€ 1,543,813) Unchanged	€ 1,573,311 Balance sheet total 2025: € 1,573,311 ▼ 4% vs 2024 (€ 1,634,683) Unchanged	▼ 4%
Employees (FTE)	3 Employees (FTE) 2022: 3 First fiscal year in the series	3.4 Employees (FTE) 2023: 3.4 ▲ 0.4 vs 2022 (3) Unchanged	3.9 Employees (FTE) 2024: 3.9 ▲ 0.5 vs 2023 (3.4) Unchanged	3.6 Employees (FTE) 2025: 3.6 ▼ 0.3 vs 2024 (3.9) Unchanged	▼ 0.3

Key figures of HEERSE APOTHEEK, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to HEERSE APOTHEEK?

What happened at HEERSE APOTHEEK in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 16, 2026 New annual accounts for financial year 2025: profit of € 43,591 (▼ 52% vs 2024). Source: NBB ↗
2005 CHEFAR BV became a director. NBB
2005 EUGENE ERNENS became a director. NBB
Nov 8, 1999 New establishment in Heers. KBO
Jul 1, 1999 Start of the company according to the CBE. KBO

In short

From € 218,705 profit in 2022 to € 43,591 profit in 2025.

Paid € 27,743 in corporate taxes since 2022.

Best year ever: 2022, with € 218,705 profit.

On average € 97,200 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

CHEFAR BV EUGENE ERNENS

Apotheek Ernens

HEERSE APOTHEEK

MANAGEMENT C.S.I.

Behind HEERSE APOTHEEK are CHEFAR BV and EUGENE ERNENS. The same people are also behind Apotheek Ernens. EUGENE ERNENS is also behind MANAGEMENT C.S.I..

Directors

According to the 2025 annual accounts

CHEFAR BV

Manager · represented by CHRISTINE ERNENS

Also active at: Apotheek Ernens

since 2005

EUGENE ERNENS

Manager

Also active at: Apotheek Ernens, MANAGEMENT C.S.I.

since 2005

Establishments

Establishment units

Physical locations of this company

Registered office

Steenweg(H.) 129

3870 Heers

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

CHEFAR same network

€ 197,931 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0466.404.110

VAT number

BE 0466.404.110

Registered office

Steenweg(H.) 129, 3870 Heers

Names & denominations

HEERSE APOTHEEK

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

1 July 1999

Peppol

Active · Active since 15 Dec 2025

Activities · NACE

Apothekers

Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗

HEERSE APOTHEEK

Warning lights

Financials

What happened to HEERSE APOTHEEK?

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions